RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
Mild or Moderate Covid-19 | NEJM https://t.co/53rO2WupxM
Mild or Moderate #COVIDー19 | NEJM https://t.co/XDMe4LDUPa
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
Mild or Moderate Covid-19 | NEJM https://t.co/57pkdjkLB1
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
Mild or moderade #COVID19 #SARS_COV_2 #hydroxychloroquine Interesting article: https://t.co/eq9mmuuy35 (via @Mendeley_com)
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
Mild or Moderate Covid-19 | NEJM State-of-the-art Covid-19 diagnosis and treatment. #BleachFree. https://t.co/sBcxuc0A1j
MILD OR MODERATE COVID 19 https://t.co/rPtmf8TcA0
RT @rahimkachra: Established & potential risk factors for severe #COVID19 include age>65, chronic lung disease, cardiovascular disease, DM,…
📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la infección: 11.5 d •Leves🏠 •Moderado o severo🏥 •Factores de riesgo para formas severas👇🏻 https://t.co/eNjEdNhmPW https://t.co/JKchXQ
RT @TxID_Edu: Mild or Moderate #COVID19 Very nice review of management by @RMKGandhi @JohnLynchID @CarlosdelRio7 https://t.co/f8NV33CRJh…
Established & potential risk factors for severe #COVID19 include age>65, chronic lung disease, cardiovascular disease, DM, obesity, immunocompromise, end-stage renal disease, and liver disease. via @NEJM https://t.co/dnpWeD3IjA
Mild or Moderate Covid-19 | NEJM https://t.co/47Luma1kD6
Mild or Moderate Covid-19 | NEJM https://t.co/5j9KBbMbRA
Very useful and practical review on typical CoVid-19 presentations not requiring critical care #CovEducation Mild or Moderate Covid-19 | NEJM https://t.co/epLAjZg1O3
NEJM Case Study #COVID19 https://t.co/ilvhh2ktoI
RT @Aiims1742: Useful supplementary material in this @NEJM vignette by @CarlosdelRio7 & colleagues listing current guidelines from various…
RT @TxID_Edu: Mild or Moderate #COVID19 Very nice review of management by @RMKGandhi @JohnLynchID @CarlosdelRio7 https://t.co/f8NV33CRJh…
That was a whirlwind! Great working with @CarlosdelRio7 and @RMKGandhi on this. Hope it helps folks working on the front-lines #COVID @UWMedicine
RT @CynthiaJacksonP: Mild or Moderate Covid-19 | NEJM ❌ Risk Factors for severe #Covid_19 https://t.co/klx0eOzelb https://t.co/Nw17iVfE…
Mild or Moderate Covid-19 | NEJM https://t.co/ItuFG6Ar2d
RT @CynthiaJacksonP: Mild or Moderate Covid-19 | NEJM ❌ Risk Factors for severe #Covid_19 https://t.co/klx0eOzelb https://t.co/Nw17iVfE…
Mild or Moderate Covid-19 | NEJM ❌ Risk Factors for severe #Covid_19 https://t.co/klx0eOzelb https://t.co/Nw17iVfE1S
Clear, concise explainer on what to expect - as the doc or the patient - if you appear to have C19
Mild or Moderate Covid-19 | NEJM https://t.co/cU7sZQZWcm
RT @TxID_Edu: Mild or Moderate #COVID19 Very nice review of management by @RMKGandhi @JohnLynchID @CarlosdelRio7 https://t.co/f8NV33CRJh…
Mild or Moderate Covid-19 | NEJM https://t.co/je0drIXdOX
Mild or Moderate Covid-19 https://t.co/xiii7NjRC5
Mild or Moderate #COVID19 Very nice review of management by @RMKGandhi @JohnLynchID @CarlosdelRio7 https://t.co/f8NV33CRJh https://t.co/j2lJICf8k1
Mild or Moderate Covid-19 | NEJM https://t.co/faoAM4ZpYI
Mild or Moderate Covid-19 | NEJM https://t.co/u6Y9KTHd1P
Useful supplementary material in this @NEJM vignette by @CarlosdelRio7 & colleagues listing current guidelines from various organizations (@WHO, @CDCgov ) & expert bodies (@IDSAInfo) on prevention, control & treatment of #COVID19. https://t.co/
Mild or Moderate #Covid-19 | NEJM https://t.co/OocGmntsci? @NEJM query=RP#.XqMagNxyCUs.twitter
New review just published in @NEJM outlines initial evaluation and treatment/management strategies for patients presenting w/ "mild" or "moderate" #COVID19 Key points highlighted in figure! https://t.co/8MD5sNlJ3Y https://t.co/tKVbwONfZU
Mild or Moderate Covid-19 | NEJM https://t.co/QjwMPxEPdD
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
Mild or Moderate Covid-19 | NEJM https://t.co/wsCAyuaA7I
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
Mild or Moderate Covid-19 | NEJM https://t.co/5184Zys5sC
Mild or Moderate Covid-19 | NEJM https://t.co/qxATbw7BCC
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled “Mild or Moderate #COVID19 https://t.co/26EmbMkwxx